FIGURE S2.-Genomic characterization of KANMX4 ectopic integrants. A) Chromosome separation by CHEF and Southern blot analysis performed using SSU1 probe on Chr. XVI, HIS5 on Chr. IX and KANMX4 showing ectopic integration. San1, control strain. E13 and E42 are two ectopic clones obtained by LiAC transformation while E11 and E14 were obtained by spheroplast transformation. B) Gene copy number determination of genes located on Chr. XVI and Chr. IX showing that no variation in the diploid chromosome condition is present in the ectopic strains. The gene dosage of VMR1, located on chromosome VIII, but not involved in translocation, was also determined as control for the accuracy of our experiments. Each analyzed gene and ACT1 were co-amplified in the same PCR reaction and data were normalized as described in Figure 3 . San1: parental strain; E13, E42, E11 and E14, ectopic clones. For other symbols and explanations see Figure 3 . FIGURE S3.-Gene expression analyses of SUC2 on glucose and raffinose. The graph reports the expression levels of SUC2 on glucose (grey bars) and on raffinose (white bars). The expression level of SUC2 was normalized with the expression level of the control gene HSC82 and then compared with the normalized expression of SUC2 in the San1 control strain considered as unit (horizontal black line). Dotted black line, two fold increase in gene expression relatively to the expression level in parental strain. FIGURE S4.-Characterization of strains carrying KANMX4 integration on either translocation break points on chromosomes XVI and IX. A) Growth test in glucose showing wild type-like growth of all the strains. Experimental conditions are described in Figure S1 . B) Gene expression analyses of chromosome XVI specific genes in I-2 and I-6 and chromosome IX specific genes in I-11 and I-17. GSH1, YCA1 and VMR1 expression was analyzed for all four KANMX4 integrants. For calculations and methods refer to Figure 8 . The relative positions of the genes on both chromosomes is schematically represented under each histogram. Amplification of integration cassette 
TABLE S3
Names, location and short description of the functions of the genes analyzed by RT-PCR.
Name of the gene Chromosome location Function

GAL4
Ch. XVI DNA-binding transcription factor required for the activation of the GAL genes in response to galactose.
CAR1
Ch. XVI Arginase, responsible for arginine degradation.
SSU1
Ch. XVI-T.B.P Plasma membrane sulfite pump involved in sulfite metabolism and required for efficient sulfite efflux.
SUC2
Ch. IX-T.B.P Invertase, sucrose hydrolyzing enzyme; a secreted, glycosylated form is regulated by glucose repression, and an intracellular, nonglycosylated enzyme is produced constitutively.
RRD1
Ch. IX Peptidyl-prolyl cis/trans-isomerase, activator of the phosphotyrosyl phosphatase activity of PP2A; involved in G1 phase progression, microtubule dynamics, bud morphogenesis and DNA repair.
MUC1
Ch. IX GPI-anchored cell surface glycoprotein (flocculin) required for pseudohyphal formation, invasive growth, flocculation, and biofilms.
DAL4
Ch. IX Allantoin permease
GLR1
Ch. XVI -T.B.P. Cytosolic and mitochondrial glutathione oxidoreductase, converts oxidized glutathione to reduced glutathione.
GSH1
Ch. X Gamma glutamylcysteine synthetase catalyzes the first step in glutathione (GSH) biosynthesis.
YCA1
Ch. XV Putative cysteine protease similar to mammalian caspases; involved in regulation of apoptosis upon hydrogen peroxide treatment.
CDC48
Ch. IV ATPase in ER, nuclear membrane and cytosol with homology to mammalian p97; in a complex with Npl4p and Ufd1p participates in retrotranslocation of ubiquitinated proteins from the ER into the cytosol for degradation by the proteasome.
CLB1
Ch. VII B-type cyclin that activates Cdc28p to promote the transition from G2 to M phase of the cell cycle.
VMR1
Ch. VIII Vacuolar multidrug resistance protein member of the ATP-binding cassette (ABC) family.
